Drug utilization by men and women: Why the differences?

Drug Information Journal

Volumn 39, Issue 3, 2005, Pages 299-310

  Neutel, C Ineke ^a   Walop, Wikke ^a  

^a PUBLIC HEALTH AGENCY OF CANADA   (Canada)

Author keywords

Drug utilization; Gender differences; National survey; Pharmacoepidemiology; Studies in women

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CANADA; DRUG INFORMATION; DRUG RESEARCH; DRUG UTILIZATION; FEMALE; GENDER; HEALTH CARE; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 23844436205     PISSN: 00928615     EISSN: None     Source Type: Journal    
DOI: 10.1177/009286150503900308     Document Type: Article

References (47)

1. Roe CM, McNamara AM, Motheral BR. Gender-and age-related prescription drug use patterns. Ann Pharmacother. 2002;36:30-39.
2. Kaufman DW, Kelly JP, Rosenberg L, Anderson TE, Mitchell AA. Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey. JAMA. 2002;287:337-344.
3. Aoki FY, Hildahl VK, Large GW, Mitenko PA, Sitar DS. Aging and heavy drug use: a prescription survey in Manitoba. J Chronic Disease. 1983;36: 75-84.
4. Graham K, Vidal-Zeballos D, Analyses of use of tranquillizers and sleeping pills across five surveys of the same population (1985-1991): the relationship with gender, age and use of other substances. Soc Sci Med. 1998;46:381-395.
5. Chen YF, Dewey ME, Avery AJ. Self-reported medication use for older people in England and Wales. J Clin Pharm Ther. 2001;26:129-140.
6. Jorgensen T, Johansson S, Kennerfalk A, Wallander MA, Svardsudd K. Prescription drug use, diagnoses, and healthcare utilization among the elderly. Ann Pharmacother. 2001;35:1004-1009.
7. Antonov K, Isacson D. Use of analgesics in Sweden-the importance of sociodemographic factors, physical fitness, health and health-related factors, and working conditions. Soc Sci Med. 1996;42:1473-1481.
8. Bjerrum L, Rosholm JU, Hallas J. Kragstrup J. Methods for estimating the occurrence of polypharmacy by means of a prescription database. Eur J Clin Pharmacol. 1997;53:7-11.
9. Arber S. Comparing inequalities in women's health and men's health: Britain in the 1990s. Soc Sci Med. 1997;44:773-787.
10. Thomas HF, Sweetnam PM, Janchawee B, Luscombe DK. Polypharmacy among older men in South Wales. Eur J Clin Pharmacol 1999;55: 411-415.
11. Eggen A. Pattern of drug use in a general population-prevalence and predicting factors: the Tromso study. Int J Epidermiol. 1994;23:1262-1272.
12. Neutel CI. Gender and family income in psychotropic drug and alcohol use. Chronic Diseases Canada. 1992;13:42-46.
13. Ashton H. Psychotropic prescribing for women. Br J Psychiatry. 1991;30-35.
14. Bertakis KD, Azari R, Helms LJ, Callahan EJ, Robbins JA. Gender differences in the utilization of health care services. J Fam Pract. 2000;49: 147-152.
15. Cafferata GL, Meyers SM. Pathways to psychotropic drugs. Understanding the basis of gender differences. Med Care. 1990;28:285-300.
16. Bertakis KD, Helms LJ, Callahan EJ, Azari R, Leigh P, Robbins JA. Patient gender differences in the diagnosis of depression in primary care. J Womens Health Gend Based Med. 2001;10:689-698.
17. Huang B, Bachmann KA, He X, Chen R, McAllister JS, Wang T. Inappropriate prescriptions for the aging population of the United States: an analysis of the National Ambulatory Medical Care Survey, 1997. Pharmacoepidemiol Drug Saf. 2002;11:127-134.
18. Stewart RB, Cooper JW. Polypharmacy in the aged. Practical solutions. Drugs Aging. 1994;4: 449-461.
19. Jones BA. Decreasing polypharmcy in clients most at risk. AACN Clinical Issues. 1997;8: 627-634.
20. Linjakumpu T, Hartikainen S, Klaukka T, Veijola J, Kivela SL, Isoaho R. Use of medications and polypharmacy are increasing among the elderly. J Clin Epidemiol. 2002;55:809-817.
21. Beers MH, Ouslander JG, Rollingher I, Reuben DB, Brooks J, Beck JC. Explicit criteria for determining inappropriate medication use in nursing home residents. UCLA Division of Geriatric Medicine. Arch Int Med. 1991;151:1825-1832.
22. Neutel CI, Walop W, Patten SB. Can continuing benzodiazepine use be predicted? Can J Clin Pharmacol. 2003;10:202-206.
23. Holbrook AM, Crowther R, Lotter A, Cheng C, King D. Meta-analysis of benzodiazepine use in the treatment of insomnia. Can Med Assoc J. 2000;162:225-233.
24. Vissers F, van der Grinten R, van der Horst F, Kester A, Knottnerus JA. Use of hypnotic and tranquillising drugs in general practice. Determinants, satisfaction and motivation to stop: the patients' view. Scand J Prim Care. 2003;21: 159-161.
25. Beaudet MP. Depression. Health Reports. 1996; 7:11-25.
26. DesMeules M, Stewart D, Editors. Women's Health Surveillance Report. A Multidimensional Look at the Health of Canadian Women. Ottawa, Canada: Health Canada; 2003.
27. Women's Health Bureau. Exploring Concepts of Gender and Health. Ottawa: Health Canada; 2003.
28. Gleiter CH, Gundert-Remy U. Gender differences in pharmacokinetics. Eur J Drug Metab Pharmacokinet. 1996;21:123-128.
29. Xie CK, Piecoro LT, Wermelin DP. Gender-related considerations in clinical pharmacology and drug therapeutics. Crit Care Nurs Clin North Am. 1997;9:459-468.
30. Tanaka E. Gender-related differences in pharmcokinetics and their clinical significance. J Clin Pharm Ther. 1999;24:339-346.
31. Harris RZ, Benet LZ, Schwartz JB. Gender effects in pharmacokinetics and pharmacodynamics. Drugs. 1995;50:222-239.
32. Meibohm B, Beierle I, Derendorf H. How important are gender differences in pharmacokinetics? Clin Pharmacokinet. 2002;41:329-349.
33. Beierle I, Meibohm B, Derendorf H. Gender differences in pharmacokinetics and pharmacodynamics. Int J Clin Pharmacol Ther. 1999;37: 529-547.
34. Prus SG, Gee E. Gender differences in the influence of economic, lifestyle, and psychosocial factors on later-life health. Can J Public Health. 2003;94:306-309.
35. Colman R. A catalyst for change: gender-based analysis and indicators for women's health in Canada. Genuine Progress Index for Atlantic Canada 2003. www.gpiatlantic.org. (Accessed May 20, 2005)
36. Mojtabai R, Olfson M. Medication costs, adherence, and health outcomes among Medicare beneficiaries. Health Aff (Millwood). 2003;22: 220-229.
37. Appelberg K, Romanov K, Honkasalo ML, Koskenvuo, M. The use of tranquillizers, hypnotics and analgesics among 18,592 Finnish adults: associations with recent interpersonal conflicts at work or with a spouse. J Clin Epidemiol. 1993;46:1315-322.
38. Mazza D, Dennerstein L. Psychotropic drug use by women: could violence account for the gender difference? J Psychosm Obstet Gynecol. 1996; 17:229-234.
39. Antonov K, Isacson D. Headache and analgesic use in Sweden. Headache. 1998;38:97-104.
40. McDonald-Miszczak L, Maki SA, Gould ON. Self-reported education adherence and health status in late adulthood: the role of beliefs. Exp Aging Res. 2000;26:189-207.
41. Benyamini Y, Leventhal EA, Leventhal H. Gender differences in processing information for making self-assessments of health. Psychosom Med. 2000; 62:354-364.
42. Verbrugge LM, Steiner RP. Physician treatment of men and women patients: sex bias or appropriate care? Med Care. 1981;19:609-632.
43. Raftery KA, Smith-Coggins R, Chen AH. Gender-associated differences in emergency department pain management. Ann Emerg Med 1995;26: 414-21.
44. Kass N. Gender and research. In Kahn JP, Mastroianni AC, Sugarman J, eds. Beyond Consent. Seeking Justice in Research. New York: Oxford University Press; 1998:67-87.
45. DeBruin DA. Justice and the inclusion of women in clinical studies: an argument for further reform. Kennedy Institute Ethics J. 1994;4: 117-146.
46. Wizemann TM. Committee on Understanding the Biology of Sex and Gender Differences. Exploring the Biological Contributions to Human Health. Does Sex Matter? Washington, DC: National Academy Press; 2001.
47. Cogliano M, Gebbie AE. Impact of the women's health initiative study. Br J Gen Pract. 2004; 54:301-302.